State-of-the-Art Biochemistry and Molecular Biology in USA 2021-2022
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (25 November 2021) | Viewed by 6165
Special Issue Editors
Interests: protein modeling and new drugs, such as structural studies of biomolecular targets, assessment of druggability, drug discovery (hit to lead through optimization) and de novo design
Special Issues, Collections and Topics in MDPI journals
Interests: hepatitis C, B, HIV, and other viral hepatitis; alcohol-associated liver disease; innate immunity; antigen presentation; proteasome; protein posttranslational modifications; animal models for a hepatitis study; long-acting drugs
Special Issues, Collections and Topics in MDPI journals
Interests: cerium oxide nano particles
Special Issues, Collections and Topics in MDPI journals
Interests: Lab-on-a-Chip/BioMEMs
Interests: alcohol-associated liver disease and metabolic dysfunction-associated liver disease: pathogenesis and treatment modality; methylation defects
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The aim of this Special Issue is to provide a comprehensive view of state-of-the-art biochemistry and molecular biology in USA. We invite research papers that will consolidate our understanding in this area. Potential topics include but are not limited to the following:
molecular biology;
structural biology;
biochemistry;
nanotechnology in biology;
Neuroscience/Neurobiology.
Dr. Thomas R. Caulfield
Prof. Dr. Natalia Osna
Prof. Dr. Joseph Erlichman
Dr. Yu Shrike Zhang
Prof. Dr. Kusum K. Kharbanda
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular biology
- structural biology
- biochemistry
- nanotechnology in biology
- Neuroscience/Neurobiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
